| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| ONCOTARGET |
| 2016 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
| ONCOTARGET |
| 2016 | Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
| NATURE COMMUNICATIONS |
| 2016 | A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
| COLD SPRING HARBOR MOLECULAR CASE STUDIES |
| 2016 | Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
| ONCOTARGET |
| 2016 | Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration | JOURNAL OF SURGICAL ONCOLOGY |
| 2016 | Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
| CANCER RESEARCH AND TREATMENT |
| 2016 | ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer | GASTROENTEROLOGY |
| 2016 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial | LANCET |
| 2016 | A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer | MOLECULAR CANCER THERAPEUTICS |
| 2016 | Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms | SUPPORTIVE CARE IN CANCER |
| 2016 | Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients | SUPPORTIVE CARE IN CANCER |
| 2016 | A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
| CANCER RESEARCH AND TREATMENT |
| 2016 | Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity
| ONCOTARGET |
| 2016 | Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | Cranofacial osteosarcoma: Single institutional experience in Korea | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
| 2016 | Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
| BMC CANCER |
| 2016 | Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis
| JOURNAL OF CANCER |
| 2016 | Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. | ANNALS OF NUCLEAR MEDICINE |
| 2016 | Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
| ONCOTARGET |
| 2016 | Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
| BMC CANCER |
| 2016 | Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
| JOURNAL OF CANCER |
| 2016 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
| ONCOTARGET |
| 2016 | Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival. | JOURNAL OF INVESTIGATIVE DERMATOLOGY |
| 2016 | Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
| YONSEI MEDICAL JOURNAL |
| 2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | ONCOLOGY |
| 2016 | PTEN Methylation Dependent Sinonasal Mucosal Melanoma
| CANCER RESEARCH AND TREATMENT |
| 2016 | p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2016 | Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference | GASTRIC CANCER |
| 2016 | Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium | CANCER |
| 2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | ANNALS OF SURGERY |
| 2015 | Prevalence of human papillomavirus infection and RAS mutation in sporadic keratoacanthoma | INTERNATIONAL JOURNAL OF DERMATOLOGY |
| 2015 | 골종양의 항암치료에 대한 전략
| Journal of the Korean Orthopaedic Association (대한정형외과학회지) |
| 2015 | hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness | ONCOGENE |
| 2015 | Caregiving burden and health-promoting behaviors among the family caregivers of cancer patients | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 2015 | The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2015 | Leiomyosarcoma: investigation of prognostic factors for risk-stratification model | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| CANCER RESEARCH AND TREATMENT |
| 2015 | Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
| GASTRIC CANCER |
| 2015 | Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10 | GYNECOLOGIC ONCOLOGY |
| 2015 | Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas | GUT |
| 2015 | Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium | CLINICAL GENITOURINARY CANCER |
| 2015 | Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium | CLINICAL GENITOURINARY CANCER |
| 2015 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study | LANCET ONCOLOGY |
| 2015 | Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer | CELLULAR SIGNALLING |
| 2015 | Caregiving burden and the quality of life of family caregivers of cancer patients: the relationship and correlates | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 2015 | Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
http://orcid.org/0000-0002-2512-4531
(7006023235)
